Cancer Diagnostics Market Industry Challenges, Key Vendors, Drivers, Trends and Forecast 2026| Grand View Research, Inc
“The global cancer diagnostics market size was valued at USD 144. 4 billion in 2018 and is expected to register a CAGR of 7.0% over the forecast period. �
The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression. Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear. Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market
Follow Us:
Further key findings from the study suggest:
Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region
Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.
Grand View Research has segmented the global cancer diagnostics market on the basis of type, application, and region: Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2014 - 2026) Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Biopsy
Others (barium enema)
Cancer Diagnostics Application Outlook (Revenue, USD Billion, 2014 - 2026) Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Kidney Cancer
Liver Cancer
Follow Us:
Pancreatic Cancer
Ovarian Cancer
Others
Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2014 - 2026) North America
o
U.S.
o
Canada
Europe o
Germany
o
U.K.
o
Spain
o
Italy
o
France
Asia Pacific o
Japan
o
China
o
India
o
Thailand
o
South Korea
Latin America o
Brazil
o
Mexico
o
Argentina
o
Columbia
Middle East and Africa (MEA) o
South Africa
o
Saudi Arabia
o
UAE
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/clinical-diagnostics
Follow Us:
Table of Content of Cancer Diagnostics Market Chapter 1 Methodology and Scope 1.1 Market Segmentation & Scope 1.2 Market Definition 1.3 Information Procurement 1.3.1 Purchased database 1.3.2 GVR’s internal database 1.3.3 Secondary sources & third party perspectives 1.3.4 Primary research 1.4 Information Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Data Visualization 1.6 Data Validation & Publishing Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Segment Outlook 2.3 Competitive Insights Chapter 3 Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent market outlook 3.1.2 Related/ancillary market outlook 3.2 Penetration & Growth Prospect Mapping 3.3 Industry Value Chain Analysis 3.3.1 Raw Material Trends 3.3.1.1 Major Raw Materials Market Analysis 3.3.1.2 Procurement Best Practices 3.3.2 Manufacturing Trends 3.3.2.1 Technology Trends 3.3.2.2 Outsourcing & Contract Manufacturing Trends 3.3.2.3 Cost Structure Analysis 3.3.3 User perspective analysis
Follow Us:
3.3.3.1 Consumer Behavior Analysis 3.3.3.2 Market Influencer Analysis 3.3.4 Procedure cost analysis/breakdown 3.3.5 List of Key End-users, by region / by product / by country 3.4 Technology Overview 3.4.1 Technology Timeline 3.5 Regulatory Framework 3.5.1 Reimbursement framework 3.5.2 Standards & Compliances 3.6 Market Dynamics 3.6.1 Market Driver Analysis 3.6.2 Market Restraint Analysis 3.6.3 Industry Challenges 3.7 Cancer Diagnostics Market Analysis Tools 3.7.1 Industry Analysis – Porter’s 3.7.1.1 Supplier Power (low; large number of small scale suppliers) 3.7.1.2 Buyer Power (High; high adoption of advanced technology) 3.7.1.3 Substitution Threat (Moderate; frequent new product launches) 3.7.1.4 Threat from new entrant (Moderate; Stringent norms to restrict entrants) 3.7.1.5 Competitive rivalry (High; consolidated market) 3.7.2 PESTEL Analysis 3.7.2.1 Political Landscape 3.7.2.2 Environmental Landscape 3.7.2.3 Social Landscape 3.7.2.4 Technology Landscape 3.7.2.5 Legal Landscape 3.7.3 Major Deals & Strategic Alliances Analysis 3.7.3.1 Joint Ventures 3.7.3.2 Mergers & Acquisitions 3.7.3.3 Licensing & Partnership 3.7.3.4 Technology Collaborations 3.7.3.5 Strategic Divestments
Follow Us:
3.7.4 Market Entry Strategies 3.7.5 Case Studies Chapter 4 Cancer Diagnostics Market: Competitive Analysis 4.1 Recent Developments & Impact Analysis, By Key Market Participants 4.2 Vendor Landscape 4.2.1 List of key distributors and channel partners 4.2.2 Key customers 4.2.3 Key company market share analysis, 2018 4.3 Public Companies 4.3.1 Company market position analysis 4.3.2 Company Market Share/Ranking, by region 4.3.3 Competitive Dashboard Analysis 4.3.3.1 Market Differentiators 4.4 Private Companies 4.4.1 List of key emerging companies’ /technology disruptors/innovators 4.4.2 Funding Outlook 4.4.3 Regional network map 4.4.4 Company market position analysis 4.4.5 Supplier Ranking Chapter 5 Cancer Diagnostics Market: Type Estimates and Trend Analysis 5.1 Definition and Scope 5.2 Type Market Share Analysis, 2018 & 2026 5.3 Segment Dashboard 5.4 Global Cancer Diagnostics Market, by Type, 2014 - 2026 (USD Million) 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026, by Type 5.5.1 Laboratory Tests 5.5.1.1 Laboratory Tests Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) 5.5.2 Genetic Tests 5.5.2.1 Genetic Tests Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) 5.5.3 Imaging 5.5.3.1 Imaging Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) 5.5.4 Endoscopy
Follow Us:
5.5.4.1 Endoscopy Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) 5.5.5 Biopsy 5.5.5.1 Biopsy Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) 5.5.6 Others 5.5.6.1 Others Market Size & Forecasts and Trend Analyses, 2014 to 2026 (USD Million) Chapter 6 Cancer Diagnostics Market: Application Estimates And Trend Analysis 6.1 Definition And Scope 6.2 Application Market Share Analysis, 2018 & 2026 6.3 Segment Dashboard 6.4 Global Cancer Diagnostics Market, By Application, 2014-2026 (USD Million) 6.5 Market Size & Forecasts And Trend Analyses, 2014 To 2026, By Application 6.5.1 Breast Cancer 6.5.1.1 Breast Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.1.2 Breast Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.2 Colorectal Cancer 6.5.2.1 Colorectal Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.2.2 Colorectal Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.3 Cervical Cancer 6.5.3.1 Cervical Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.3.2 Cervical Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.4 Lung Cancer 6.5.4.1 Lung Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.4.2 Lung Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.5 Prostate Cancer 6.5.5.1 Prostate Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026(USD Million) 6.5.5.2 Prostate Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.6 Skin Cancer 6.5.6.1 Skin Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.6.2 Skin Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.7 Blood Cancer 6.5.7.1 Blood Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million)
Follow Us:
6.5.7.2 Blood Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.8 Kidney Cancer 6.5.8.1 Kidney Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.8.2 Kidney Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.9 Liver Cancer 6.5.9.1 Liver Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.9.2 Liver Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.10 Pancreatic Cancer 6.5.10.1 Pancreatic Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.10.2 Pancreatic Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.11 Ovarian Cancer 6.5.11.1 Ovarian Cancer Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.11.2 Ovarian Cancer Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026 (USD Million) 6.5.12 Others 6.5.12.1 Others Market Size & Forecasts And Trend Analyses, 2014 To 2026 (USD Million) 6.5.12.2 Others Market Size & Forecasts And Trend Analyses, By Type 2014 To 2026(USD Million) Chapter 7 Cancer Diagnostics Market Regional Estimates & Trend Analysis, by Product & Application 7.1 Regional Market Snapshot 7.2 Regional Market Share and Leading Players, 2018 7.2.1 North America 7.2.2 Europe 7.2.3 Asia Pacific 7.2.4 Latin America 7.2.5 Middle East & Africa 7.3 Market Share Analysis by Country/ State 7.3.1 North America 7.3.2 Europe 7.3.3 Asia Pacific 7.3.4 Latin America 7.3.5 Middle East & Africa 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Follow Us:
7.4.1 North America 7.4.2 Europe 7.4.3 Asia Pacific 7.4.4 Latin America 7.4.5 Middle East & Africa 7.5 Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 7.6 North America 7.6.1 North America Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.6.2 U.S. 7.6.2.1 U.S. Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.6.3 Canada 7.6.3.1 Canada Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7 Europe 7.7.1 Europe Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7.2 U.K. 7.7.2.1 U.K. Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7.3 Germany 7.7.3.1 Germany Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7.4 Italy 7.7.4.1 Italy Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7.5 Spain 7.7.5.1 Spain Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.7.6 France 7.7.6.1 France Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.8 Asia Pacific 7.8.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.8.2 China 7.8.2.1 China Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.8.3 Japan 7.8.3.1 Japan Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.8.4 India 7.8.4.1 India Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million)
Follow Us:
7.8.5 Thailand 7.8.5.1 Thailand market size, & forecasts and trend analysis, 2014 to 2026 (usd million) 7.8.6 South Korea 7.8.6.1 South Korea Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.9 Latin America 7.9.1 Latin America Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.9.2 Brazil 7.9.2.1 Brazil Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.9.3 Mexico 7.9.3.1 Mexico Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.9.4 Argentina 7.9.4.1 Argentina Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.9.5 Columbia 7.9.5.1 Columbia Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.10 Middle East and Africa 7.10.1 Middle East and Africa Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.10.2 South Africa 7.10.2.1 South Africa Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.10.3 Saudi Arabia 7.10.3.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) 7.10.4 UAE 7.10.4.1 UAE Market Size, & Forecasts and Trend Analysis, 2014 TO 2026 (USD Million) Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company overview 8.1.2 Financial performance 8.1.3 Product benchmarking 8.1.4 Strategic initiatives 8.2 Qiagen N.V. 8.2.1 Company overview 8.2.2 Financial performance 8.2.3 Product benchmarking
Follow Us:
8.2.4 Strategic initiatives 8.3 F. Hoffmann-La Roche Ltd. 8.3.1 Company overview 8.3.2 Financial performance 8.3.3 Product benchmarking 8.3.4 Strategic initiatives 8.4 Siemens Healthineers 8.4.1 Company overview 8.4.2 Financial performance 8.4.3 Product benchmarking 8.4.4 Strategic initiatives 8.5 Thermo Fisher Scientific, Inc. 8.5.1 Company overview 8.5.2 Financial performance 8.5.3 Product benchmarking 8.5.4 Strategic initiatives 8.6 GE Healthcare 8.6.1 Company overview 8.6.2 Financial performance 8.6.3 Product benchmarking 8.6.4 Strategic initiatives 8.7 Hologic, Inc. 8.7.1 Company overview 8.7.2 Financial performance 8.7.3 Product benchmarking 8.7.4 Strategic initiatives 8.8 Becton Dickinson & Company 8.8.1 Company overview 8.8.2 Financial performance 8.8.3 Product benchmarking 8.8.4 Strategic initiatives 8.9 Koninklijke Philips N.V. (Philips)
Follow Us:
8.9.1 Company overview 8.9.2 Financial performance 8.9.3 Product benchmarking 8.9.4 Strategic initiatives 8.10 Illumina, Inc. 8.10.1 Company overview 8.10.2 Financial performance 8.10.3 Product benchmarking 8.10.4 Strategic initiatives
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: